Recent stories zum Coronavirus

Swiss Rockets AG

Swiss Rockets AG announces the founding of ROCKETVAX for the development of a next-generation SARS-CoV-2 vaccine

IntellIoT

European Commission launches EUR 8 million Next-Generation IoT environments project amid Covid-19 pandemic

nal von minden GmbH

New: Combined rapid test for Covid-19 and influenza

nal von minden GmbH

New Covid-19 antigen test: Fast and reliable results in just 15 minutes

Technische Universität München

Coronavirus: door opener facilates cell entry

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22562 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36263/ NEWS RELEASE How the virus enters the cell Coronavirus: Neuropilin-1 could open the door to the inside of the cell The protein neuropilin-1 facilitates SARS CoV-2 cell entry. A research team including ...

Luoro GmbH

Revolutionary face mask can prevent cross-contamination

Solita

Finnish coronavirus tracing app Koronavilkku reaches 2 million downloads

Helsinki (ots) - The Finnish Koronavilkku ('Corona Blinker') application, which helps to break chains of coronavirus infection, has already been downloaded over 2 million times. The milestone of 2 million downloads - 37 % of the population - was reached two weeks after the application became available for download in app stores. 'We all now have a genuine opportunity ...

Foreign office of Kazakhstani opposition

Akezhan Kazhegeldin calls on President Tokayev to carry out political and economic reforms / Former Kazakh Prime Minister proposes emergency measures to overcome the current crisis

Dr. Rath Education Services BV

Micronutrient Combination Suppresses Cell 'Entry Door' For Coronavirus

IgNova GmbH

IgNova files patent application on antibody against COVID-19

Visbek, Germany (ots) - IgNova announced today that it has filed a patent application covering the use of passive immunization to control SARS-CoV-2 infection in humans. IgNova, a biopharmaceutical R&D start up, researches technology based on specific egg immunoglobulins (IgY). The patented IgY binds the spike protein of SARS-CoV-2, neutralizing the virus when it enters the mouth or nose and, therefore, inhibiting the ...

DERMALOG Identification Systems GmbH

DERMALOG Contactless Fever Checks at Medical Practices

Proctorio

Amsterdam District Court Decides In Favor of Proctorio and University of Amsterdam

Scottsdale (ots) - Win for Proctorio and online education as a whole. Students of UvA and other similar universities can now continue their education from their own home without sacrificing integrity or the validity of the degrees they earned. With the rapid spread of COVID-19, universities all over the world have been forced to transfer their physical learning ...

DERMALOG Identification Systems GmbH

DERMALOG Fever Check at Greifswald University Hospital

Pentahotels

Pentahotels are welcoming back business and leisure guests after national COVID-19 lockdowns

DERMALOG Identification Systems GmbH

DERMALOG Fever Check at the MAhL ZEIT Homeless Day Center in Hamburg

Mediaform Informationssysteme GmbH

The Mediaform group of companies is working towards the launch of an EU Health Passport

eleva GmbH

Eleva's drug candidate to be examined for use in Covid-19 treatment

Freiburg (ots) - Eleva, a manufacturer of superior biologics, is exploring the potential of one of its drug candidates for first-in-line therapy of Covid-19. The compound, factor H, is part of the complement system, which is believed to affect the severity of the course of Covid-19. Eleva has developed factor H previously for a different indication and taken it through ...

DERMALOG Identification Systems GmbH

DERMALOG Temperature Check: Greater Safety for Medical Practices

DERMALOG Identification Systems GmbH

DERMALOG Fever Check at German Baltic Hotel

DERMALOG Identification Systems GmbH

Retailers rely on DERMALOG's Fever Screening

DERMALOG Identification Systems GmbH

DERMALOG Fever Detection protects Drägerwerk AG Production

Fluxergy

2

FLUXERGY ANNOUNCES $30 MILLION TO EXPAND MANUFACTURING CAPACITY OF ITS ONE-HOUR POINT-OF-CARE DIAGNOSTIC TESTING SYSTEM IN RESPONSE TO COVID-19

DERMALOG Identification Systems GmbH

DERMALOG Fever Detection at UKE Hamburg

Richnerstutz AG

2

Covid19 solution for retailers: Smart counting system helps customers to keep their distance